CAS No.38006-08-5,Sulfamonomethoxine sodium Suppliers

Products Categories

Pharmaceutical (90)
Others (47)
Organic Chemicals (14)
Reagent (1)
Food Additives (1)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	38006-08-5
Name:	Sulfamonomethoxine sodium

Formula:	C₁₁H₁₂N₄NaO₃S
Molecular Weight:	303.05
Synonyms:	Benzenesulfonamide,4-amino-N-(6-methoxy-4-pyrimidinyl)-, monosodium salt (9CI);Sodiumsulfamonomethoxine;Sulfamonomethoxine sodium salt;4-Methoxy-6-sulfanilamidopyrimidine sodium salt;
Boiling Point:	513.2 °C at 760 mmHg
Flash Point:	264.2 °C
PSA:	106.79000
LogP:	2.38900

Total:95 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 38006-08-5

Specification

This product is an organic compound with the formula C₁₁H₁₂N₄NaO₃S. The systematic name of this chemical is Benzenesulfonamide,4-amino-N-(6-methoxy-4-pyrimidinyl)-, sodium salt (1:1). With the CAS registry number 38006-08-5, it is also named as 4-Methoxy-6-sulfanilamidopyrimidine sodium salt. In addition, the molecular weight is 303.05. Its classification code is Drug / Therapeutic Agent. It is a long acting sulfonamide antibacterial agent.

Physical properties of Benzenesulfonamide,4-amino-N-(6-methoxy-4-pyrimidinyl)-, sodium salt (1:1) are: (1)ACD/LogP: -0.04; (2)# of Rule of 5 Violations: 0; (3)#H bond acceptors: 7; (4)#H bond donors: 3; (5)#Freely Rotating Bonds: 3; (6)Polar Surface Area: 84.01 Å²; (7)Flash Point: 264.2 °C; (8)Enthalpy of Vaporization: 78.46 kJ/mol; (9)Boiling Point: 513.2 °C at 760 mmHg; (10)Vapour Pressure: 1.2E-10 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].O=S(=O)(Nc1ncnc(OC)c1)c2ccc(N)cc2
(2)Std. InChI: InChI=1S/C11H12N4O3S.Na/c1-18-11-6-10(13-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9;/h2-7H,12H2,1H3,(H,13,14,15);/q;+1
(3)Std. InChIKey: QHALTWCNEVUKBB-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
chicken	LD50	intravenous	1380mg/kg (1380mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: FOOD INTAKE (ANIMAL) LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA	Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
chicken	LD50	oral	7250mg/kg (7250mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: FOOD INTAKE (ANIMAL) LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA	Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
dog	LD50	intravenous	792mg/kg (792mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA	Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
mouse	LD50	intraperitoneal	1070mg/kg (1070mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
mouse	LD50	intravenous	1010mg/kg (1010mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
mouse	LD50	oral	3240mg/kg (3240mg/kg)		Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
mouse	LD50	subcutaneous	1gm/kg (1000mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
rabbit	LD50	intravenous	1530mg/kg (1530mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
rat	LD50	intravenous	1710mg/kg (1710mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: IRRITABILITY LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA	Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
rat	LD50	oral	5620mg/kg (5620mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: IRRITABILITY LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA	Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
rat	LD50	subcutaneous	1730mg/kg (1730mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: IRRITABILITY LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA	Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.